Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02664961
Title Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Tracon Pharmaceuticals Inc.
Indications

trophoblastic neoplasm

Therapies

Bevacizumab + Carotuximab

Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.